Collegium Pharmaceutical Inc (COLL)
EBITDA Margin
58.57%
TTM · Period ending:
COLL EBITDA Margin
Latest reported58.57%period ending
Latest reported58.57%period ending
COLL TTM EBITDA Margin (-18514.22% → 58.57%)
TTM ebitda margin
High-resolution chart · PNG
COLL ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 58.5744% | |
| 62.299% | |
| 62.3274% | |
| 51.8733% | |
| 49.0417% | |
| 50.0966% | |
| 54.114% | |
| 57.8596% | |
| 62.0309% | |
| 62.7193% | |
| 54.4012% | |
| 48.0684% | |
| 43.6873% | |
| 39.2097% | |
| 37.3556% | |
| 27.7921% | |
| 23.4111% | |
| 21.1636% | |
| 31.2629% | |
| 41.6027% | |
| 43.1618% | |
| 43.7938% | |
| 38.0671% | |
| 28.522% | |
| 16.3072% | |
| 5.0319% | |
| -2.1335% | |
| 6.455% | |
| 14.6821% | |
| 23.786% | |
| 32.7767% | |
| 21.7242% | |
| 7.6795% | |
| -38.1387% | |
| -260.8196% | |
| -443.9347% | |
| -1,307.5238% | |
| -2,594.6948% | |
| -5,460.3156% | |
| -18,514.2157% |